Addressing the aforementioned gap in knowledge, our study specifically delved into examining the correlation between specific variants of HVEM and CD160 genes and their potential influence on susceptibility to ccRCC as well as ccRCC patients’ overall survival (OS). Here, CD160 is linked to nonpapillary renal cell carcinoma.